The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 22, 2015
Filed:
Jul. 03, 2013
Applicant:
University Health Network, Toronto, CA;
Inventors:
Peter Brent Sampson, Oakville, CA;
Yong Liu, Oakville, CA;
Sze-Wan Li, Toronto, CA;
Bryan T. Forrest, Burlington, CA;
Heinz W. Pauls, Oakville, CA;
Louise G. Edwards, Mississauga, CA;
Miklos Feher, New York, NY (US);
Narendra Kumar B. Patel, Brampton, CA;
Radoslaw Laufer, Oakville, CA;
Assignee:
University Health Network, Toronto, CA;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); C07D 403/04 (2006.01); C07D 413/14 (2006.01); C07D 231/56 (2006.01); C07D 403/10 (2006.01); C07D 403/14 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 231/56 (2013.01); C07D 403/10 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01);
Abstract
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.